JUN HENG HEALTHCARE INTERNATIONAL LIMITED – Trademark Portfolio

Entity Type: 16

JUN HENG HEALTHCARE INTERNATIONAL LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ZSXDFOO. The owner is based in HONG KONG.

ROOMS 1318-19,13/F,HOLLYWOODPLAZA, 610

NATHAN, ROAD,MONGKOK,KL

HONG KONG , HK

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ZSXDFOO
ZSXDFOO
Registered 2020

Trademark Classifications

JUN HENG HEALTHCARE INTERNATIONAL LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does JUN HENG HEALTHCARE INTERNATIONAL LIMITED have?

JUN HENG HEALTHCARE INTERNATIONAL LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does JUN HENG HEALTHCARE INTERNATIONAL LIMITED file in?

JUN HENG HEALTHCARE INTERNATIONAL LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are JUN HENG HEALTHCARE INTERNATIONAL LIMITED's most well-known trademarks?

JUN HENG HEALTHCARE INTERNATIONAL LIMITED's registered trademark portfolio includes well-known marks such as ZSXDFOO. These are among 1 currently registered trademark in the portfolio.

What is JUN HENG HEALTHCARE INTERNATIONAL LIMITED's trademark registration success rate?

JUN HENG HEALTHCARE INTERNATIONAL LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.